Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Molecular Medicine, |
RCV001786545 | SCV002028375 | likely pathogenic | Seizures, benign familial neonatal, 1; Developmental and epileptic encephalopathy, 7 | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001885202 | SCV002257018 | uncertain significance | Early infantile epileptic encephalopathy with suppression bursts | 2023-08-18 | criteria provided, single submitter | clinical testing | An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1326323). This variant has not been reported in the literature in individuals affected with KCNQ2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 129 of the KCNQ2 protein (p.Leu129Val). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |